182 related articles for article (PubMed ID: 24414229)
21. Influence of Piracetam on Gliclazide-Glycated Human Serum Albumin Interaction. A Spectrofluorometric Study.
Szkudlarek A; Pożycka J; Maciążek-Jurczyk M
Molecules; 2018 Dec; 24(1):. PubMed ID: 30597970
[TBL] [Abstract][Full Text] [Related]
22. Alginate as an antiglycating agent for human serum albumin.
Sattarahmady N; Khodagholi F; Moosavi-Movahedi AA; Heli H; Hakimelahi GH
Int J Biol Macromol; 2007 Jul; 41(2):180-4. PubMed ID: 17350677
[TBL] [Abstract][Full Text] [Related]
23. Genotoxicity of advanced glycation end products in vitro is influenced by their preparation temperature, purification and cell exposure time.
Jaunay EL; Dhillon VS; Semple SJ; Simpson BS; Ghetia M; Deo P; Fenech M
Mutagenesis; 2021 Nov; 36(6):445-455. PubMed ID: 34612487
[TBL] [Abstract][Full Text] [Related]
24. Amadori product and age formation during nonenzymatic glycosylation of bovine serum albumin in vitro.
Sharma SD; Pandey BN; Mishra KP; Sivakami S
J Biochem Mol Biol Biophys; 2002 Aug; 6(4):233-42. PubMed ID: 12186738
[TBL] [Abstract][Full Text] [Related]
25. Quantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI-TOF MS.
Barnaby OS; Cerny RL; Clarke W; Hage DS
Clin Chim Acta; 2011 Aug; 412(17-18):1606-15. PubMed ID: 21601565
[TBL] [Abstract][Full Text] [Related]
26. An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.
Neelofar K; Ahmad J
Glycoconj J; 2017 Oct; 34(5):575-584. PubMed ID: 28812216
[TBL] [Abstract][Full Text] [Related]
27. New insights into non-enzymatic glycation of human serum albumin biopolymer: A study to unveil its impaired structure and function.
Raghav A; Ahmad J; Alam K; Khan AU
Int J Biol Macromol; 2017 Aug; 101():84-99. PubMed ID: 28322944
[TBL] [Abstract][Full Text] [Related]
28. Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Wa C; Cerny RL; Clarke WA; Hage DS
Clin Chim Acta; 2007 Oct; 385(1-2):48-60. PubMed ID: 17707360
[TBL] [Abstract][Full Text] [Related]
29. Alteration of human serum albumin tertiary structure induced by glycation. Spectroscopic study.
Szkudlarek A; Maciążek-Jurczyk M; Chudzik M; Równicka-Zubik J; Sułkowska A
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 153():560-5. PubMed ID: 26433342
[TBL] [Abstract][Full Text] [Related]
30. Comparison of modification sites formed on human serum albumin at various stages of glycation.
Barnaby OS; Cerny RL; Clarke W; Hage DS
Clin Chim Acta; 2011 Jan; 412(3-4):277-85. PubMed ID: 21034726
[TBL] [Abstract][Full Text] [Related]
31. Thermal aggregation of glycated bovine serum albumin.
Rondeau P; Navarra G; Cacciabaudo F; Leone M; Bourdon E; Militello V
Biochim Biophys Acta; 2010 Apr; 1804(4):789-98. PubMed ID: 20006741
[TBL] [Abstract][Full Text] [Related]
32. A study on human serum albumin influence on glycation of fibrinogen.
Kielmas M; Szewczuk Z; Stefanowicz P
Biochem Biophys Res Commun; 2013 Sep; 439(1):78-83. PubMed ID: 23958299
[TBL] [Abstract][Full Text] [Related]
33. Reactivities of D-glucose and D-fructose during glycation of bovine serum albumin.
Yeboah FK; Alli I; Yaylayan VA
J Agric Food Chem; 1999 Aug; 47(8):3164-72. PubMed ID: 10552625
[TBL] [Abstract][Full Text] [Related]
34. Glycation of interferon-beta-1b and human serum albumin in a lyophilized glucose formulation. Part III: application of proteomic analysis to the manufacture of biological drugs.
Zheng X; Wu SL; Hancock WS
Int J Pharm; 2006 Sep; 322(1-2):136-45. PubMed ID: 16920285
[TBL] [Abstract][Full Text] [Related]
35. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
[TBL] [Abstract][Full Text] [Related]
36. Structural and immunological characterization of Amadori-rich human serum albumin: role in diabetes mellitus.
Arif B; Ashraf JM; Moinuddin ; Ahmad J; Arif Z; Alam K
Arch Biochem Biophys; 2012 Jun; 522(1):17-25. PubMed ID: 22516656
[TBL] [Abstract][Full Text] [Related]
37. Interaction between glycated serum albumin and AGE-receptors depends on structural changes and the glycation reagent.
Indurthi VS; Leclerc E; Vetter SW
Arch Biochem Biophys; 2012 Dec; 528(2):185-96. PubMed ID: 23079546
[TBL] [Abstract][Full Text] [Related]
38. Elucidating the impact of glucosylation on human serum albumin: A multi-technique approach.
Neelofar KM; Ahmad J; Arif Z; Alam K
Int J Biol Macromol; 2016 Nov; 92():881-891. PubMed ID: 27492562
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of colchicine on albumin glycation and cellular oxidative stress: Insights into diabetic cardiomyopathy.
Thakur MR; Tupe RS
J Biochem Mol Toxicol; 2024 Mar; 38(3):e23664. PubMed ID: 38372178
[TBL] [Abstract][Full Text] [Related]
40. Detection of glycation sites in proteins by high-resolution mass spectrometry combined with isotopic labeling.
Stefanowicz P; Kijewska M; Kluczyk A; Szewczuk Z
Anal Biochem; 2010 May; 400(2):237-43. PubMed ID: 20156417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
